Tactiva Therapeutics, an immuno-oncology company and UB partner, is poised for growth in 2019.


Lined with bird shelters and bat boxes, “Life Support” is a living art sculpture that will serve as a functional habitat for a wide variety of bats, birds and reptiles.


Aesku.NY, a UB partner, has growing operations on the Buffalo Niagara Medical Campus.


Study seeks to identify new genes associated with breast cancer risk in African American women.


TRELIS builds leadership capacity among women who work in geographic information science in higher education.


In the Democratic Republic of the Congo, peace and economic opportunity are percolating, thanks to UB efforts to develop a more inclusive coffee value chain.


Numerous smoking cessation therapies are on the market, but actually quitting for good is still a major challenge for many smokers. Now, a University at Buffalo researcher has been awarded a five-year, $2 million grant to investigate a novel therapy.


Study's findings on nitrogen dioxide suggest that China's air pollution standard for NO2 may need to be re-evaluated.


  People who narrowly avoid disaster do not necessarily escape tragedy unharmed, and their knowledge of the victims’ fate shapes how survivors respond to traumatic events, according to the results of a new paper by a UB psychologist.  


UB’s physics department is hosting a conference for Large Hadron Collider researchers this week.


UB researchers’ insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer’s drugs.